
Meribank Biotech Co., also known as 宣捷幹細胞, is a leading biotechnology company specializing in mesenchymal stem cell (MSC) technologies including manufacturing, characterization, storage, and drug discovery. The company integrates advanced technologies such as machine learning and artificial intelligence to develop smart medical products aimed at precision medicine. Meribank operates a stem cell research and storage center compliant with US FDA and PIC/S GMP pharmaceutical standards, supporting clinical trials for stem cell drugs. Their proprietary technology enables large-scale culture of high-quality MSCs and exosomes, with applications in regenerative medicine, immune cell therapies, and cosmetic ingredients. The company collaborates with hospitals and research institutions, serving over 300 obstetrics and gynecology medical facilities across Taiwan, and has achieved international certifications and patents. Meribank's business model includes cell storage services, stem cell drug development, and clinical collaborations, positioning it as a trusted innovator in the regenerative medicine and biotechnology industry with a strong focus on preventive medicine and health care for all ages.

Meribank Biotech Co., also known as 宣捷幹細胞, is a leading biotechnology company specializing in mesenchymal stem cell (MSC) technologies including manufacturing, characterization, storage, and drug discovery. The company integrates advanced technologies such as machine learning and artificial intelligence to develop smart medical products aimed at precision medicine. Meribank operates a stem cell research and storage center compliant with US FDA and PIC/S GMP pharmaceutical standards, supporting clinical trials for stem cell drugs. Their proprietary technology enables large-scale culture of high-quality MSCs and exosomes, with applications in regenerative medicine, immune cell therapies, and cosmetic ingredients. The company collaborates with hospitals and research institutions, serving over 300 obstetrics and gynecology medical facilities across Taiwan, and has achieved international certifications and patents. Meribank's business model includes cell storage services, stem cell drug development, and clinical collaborations, positioning it as a trusted innovator in the regenerative medicine and biotechnology industry with a strong focus on preventive medicine and health care for all ages.